Key Metrics
3.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.91
5-Year SI
5-year SI
- N/A 2-year SI
- 0.91 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Biochemistry, Genetics and Molecular Biology (all)
SJR
- Q2 Biochemistry, Genetics and Molecular Biology (all)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.62
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
24%
4 to 6 months
53%
7 to 9 months
16%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Hepatocellular carcinoma
- Lung cancer
- Gene expression
- Oxidative stress
- Antioxidant
- Colorectal cancer
- Assay
- Cytochrome P450
- Extracellular vesicles
- Cell cycle
- Learning gain
- HeLa
- Diabetic nephropathy
- Fatty liver
- Femoral head
- Carcinogenesis
- Lipopolysaccharide
- Crystal structure
- Osteosarcoma
- Cervical cancer
Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 1750 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Federation of European Biochemical Societies |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 10 |
| Article Processing Charges | USD 1750 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in FEBS Open Bio ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione mediates the effect of ROS-enhanced PI3K/Akt/mTOR pathway on autophagy in breast cancer.
- 9 Dec 24
- FEBS open bio
-
Full paper
RETRACTION: XBP1 Inhibits Mesangial Cell Apoptosis in Response to Oxidative Stress via the PTEN/AKT Pathway in Diabetic Nephropathy.
- 6 Dec 24
- FEBS open bio
-
Full paper
RETRACTION: LKB1 Suppresses Androgen Synthesis in a Mouse Model of Hyperandrogenism via IGF-1 Signaling.
- 6 Dec 24
- FEBS open bio
-
Full paper
RETRACTION: MicroRNA-498 Reduces the Proliferation and Invasion of Colorectal Cancer Cells via Targeting Bcl-2.
- 6 Dec 24
- FEBS open bio
-
Full paper
RETRACTION: NGF Protects Neuroblastoma Cells Against β-Amyloid-Induced Apoptosis via the Nrf2/HO-1 pathway.
- 6 Dec 24
- FEBS open bio
-
Full paper
RETRACTION: CDKL5 Promotes Proliferation, Migration, and Chemotherapeutic Drug Resistance of Glioma Cells via Activation of the PI3K/AKT Signaling Pathway.
- 6 Dec 24
- FEBS open bio
Scite analysis
Powered by scite_
2.4k articles received 22.4k citations see all
- 1,053 Supporting
- 21,059 Mentioning
- 100 Contrasting
Editorial notices
- 32 Retractions
- 4 Withdrawals
- 22 Corrections
- 22 Errata
- 0 Expression of Concern
FAQs
How long has FEBS Open Bio been actively publishing?
FEBS Open Bio has been in operation since 2011 till date.
What is the publishing frequency of FEBS Open Bio ?
FEBS Open Bio published with a Continuous publication frequency.
How many articles did FEBS Open Bio publish last years ?
In 2023, FEBS Open Bio published 228 articles.
What is the eISSN & pISSN for FEBS Open Bio ?
For FEBS Open Bio,eISSN is 2211-5463 and pISSN is2211-5463.
What is Citescore for FEBS Open Bio ?
Citescore for FEBS Open Bio is 3.9.
What is SNIP score for FEBS Open Bio ?
SNIP score for FEBS Open Bio is 0.62.
What is the SJR for FEBS Open Bio ?
SJR for FEBS Open Bio is Q2.
Who is the publisher of FEBS Open Bio ?
WILEY is the publisher of FEBS Open Bio.